reported that YTHDF2 was upregulated in mesenchymal GBM and its depletion increased the VEGFA transcript decay rate in GBM stem cells in an m6A-dependent manner, thus affecting tumor angiogenesis (185). The gene discussed is VEGFA; the disease is glioblastoma.